Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 5
1964 7
1965 5
1966 7
1967 10
1968 13
1969 32
1970 23
1971 37
1972 37
1973 22
1974 38
1975 25
1976 20
1977 37
1978 34
1979 35
1980 22
1981 25
1982 31
1983 32
1984 47
1985 52
1986 47
1987 45
1988 63
1989 70
1990 100
1991 111
1992 140
1993 151
1994 212
1995 185
1996 217
1997 245
1998 240
1999 226
2000 250
2001 274
2002 284
2003 295
2004 255
2005 273
2006 308
2007 339
2008 291
2009 316
2010 334
2011 344
2012 323
2013 430
2014 448
2015 475
2016 477
2017 512
2018 418
2019 450
2020 481
2021 465
2022 461
2023 336

Text availability

Article attribute

Article type

Publication date

Search Results

10,643 results

Results by year

Filters applied: . Clear all
Page 1
B Cell Lymphoma.
Meng X, Min Q, Wang JY. Meng X, et al. Adv Exp Med Biol. 2020;1254:161-181. doi: 10.1007/978-981-15-3532-1_12. Adv Exp Med Biol. 2020. PMID: 32323276 Review.
Abnormalities in these genetic events can cause chromosomal translocations and genomic mutations, leading to altered expression and function of genes involved in B cell survival or proliferation and consequently B lymphomagenesis. In fact, B cell …
Abnormalities in these genetic events can cause chromosomal translocations and genomic mutations, leading to altered expression and function …
Cutaneous B-Cell Lymphoma.
Goyal A, LeBlanc RE, Carter JB. Goyal A, et al. Hematol Oncol Clin North Am. 2019 Feb;33(1):149-161. doi: 10.1016/j.hoc.2018.08.006. Hematol Oncol Clin North Am. 2019. PMID: 30497672 Review.
There are 3 types of primary cutaneous B-cell lymphomas: primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg-type. Because it is most freque …
There are 3 types of primary cutaneous B-cell lymphomas: primary cutaneous marginal zone lymphoma, primary cutaneous fo …
High-grade B-cell lymphoma: how to diagnose and treat.
Novo M, Castellino A, Nicolosi M, Santambrogio E, Vassallo F, Chiappella A, Vitolo U. Novo M, et al. Expert Rev Hematol. 2019 Jul;12(7):497-506. doi: 10.1080/17474086.2019.1624157. Epub 2019 Jun 19. Expert Rev Hematol. 2019. PMID: 31150587 Review.
Introduction: High Grade B-cell Lymphomas (HGBL) have been defined as a new separate entity in 2016 revised WHO classification of lymphoid neoplasms. ...
Introduction: High Grade B-cell Lymphomas (HGBL) have been defined as a new separate entity in 2016 revised WHO classification …
Double hit and double expressors in lymphoma: Definition and treatment.
Riedell PA, Smith SM. Riedell PA, et al. Cancer. 2018 Dec 15;124(24):4622-4632. doi: 10.1002/cncr.31646. Epub 2018 Sep 25. Cancer. 2018. PMID: 30252929 Free article. Review.
Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy for aggressive B-cell lymphomas. The identification of concurrent MYC and B-cell CLL/lymphoma 2 (BCL2) de …
Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy …
Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.
Liu Y, Zhou X, Wang X. Liu Y, et al. J Hematol Oncol. 2021 Aug 17;14(1):125. doi: 10.1186/s13045-021-01134-x. J Hematol Oncol. 2021. PMID: 34404434 Free PMC article. Review.
B-cell lymphoma is a group of hematological malignancies with high clinical and biological heterogeneity. ...Here, we epitomize the recent advances of TME in B-cell lymphoma and discuss its function in tumor progression and immune escape. …
B-cell lymphoma is a group of hematological malignancies with high clinical and biological heterogeneity. ...Here, we e …
Mechanisms of B-cell lymphoma pathogenesis.
Küppers R. Küppers R. Nat Rev Cancer. 2005 Apr;5(4):251-62. doi: 10.1038/nrc1589. Nat Rev Cancer. 2005. PMID: 15803153 Review.
Chromosomal translocations involving the immunoglobulin loci are a hallmark of many types of B-cell lymphoma. Other factors, however, also have important roles in the pathogenesis of B-cell malignancies. Most B-cell lymphomas depen …
Chromosomal translocations involving the immunoglobulin loci are a hallmark of many types of B-cell lymphoma. Other fac …
Treatment of relapsed/refractory paediatric aggressive B-cell non-Hodgkin lymphoma.
Moleti ML, Testi AM, Foà R. Moleti ML, et al. Br J Haematol. 2020 Jun;189(5):826-843. doi: 10.1111/bjh.16461. Epub 2020 Mar 6. Br J Haematol. 2020. PMID: 32141616 Free article. Review.
Aggressive B-cell non-Hodgkin lymphoma (B-NHL) accounts for 60% of NHL in children/adolescents. In newly diagnosed Burkitt lymphoma and diffuse large B-cell lymphoma, short intensive multiagent chemotherapy is associated wit …
Aggressive B-cell non-Hodgkin lymphoma (B-NHL) accounts for 60% of NHL in children/adolescents. In newly diagnos …
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.
Kesavan M, Eyre TA, Collins GP. Kesavan M, et al. Curr Hematol Malig Rep. 2019 Aug;14(4):207-218. doi: 10.1007/s11899-019-00518-8. Curr Hematol Malig Rep. 2019. PMID: 31254155 Free PMC article. Review.
PURPOSE OF REVIEW: Rituximab-based chemoimmunotherapy has resulted in a marked improvement in the survival of diffuse large B cell lymphoma (DLBCL). We reflect upon the history front-line (1L) therapy and highlight advances in management. ...Accumulating evid …
PURPOSE OF REVIEW: Rituximab-based chemoimmunotherapy has resulted in a marked improvement in the survival of diffuse large B cell …
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
Grimm KE, O'Malley DP. Grimm KE, et al. Ann Diagn Pathol. 2019 Feb;38:6-10. doi: 10.1016/j.anndiagpath.2018.09.014. Epub 2018 Oct 2. Ann Diagn Pathol. 2019. PMID: 30380402 Review.
The recent 2017 update of the World Health Organization classification of lymphomas has significant changes from the previous edition. Subtypes of large B cell lymphoma and related aggressive B cell lymphomas are addressed. ...Specific subtypes …
The recent 2017 update of the World Health Organization classification of lymphomas has significant changes from the previous edition. Subty …
How I manage patients with grey zone lymphoma.
Kritharis A, Pilichowska M, Evens AM. Kritharis A, et al. Br J Haematol. 2016 Aug;174(3):345-50. doi: 10.1111/bjh.14174. Epub 2016 Jun 15. Br J Haematol. 2016. PMID: 27301470 Free article. Review.
Since grey zone lymphoma (GZL) was originally included in the 2008 World Health Organization classification as a B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma (DLBCL) and classical …
Since grey zone lymphoma (GZL) was originally included in the 2008 World Health Organization classification as a B-cell …
10,643 results
You have reached the last available page of results. Please see the User Guide for more information.